Pharmaceutical News

RSS
Swine flu vaccine distribution plan for Pennsylvania

Swine flu vaccine distribution plan for Pennsylvania

EMD Serono submits NDA for Cladribine Tablets in the U.S.

EMD Serono submits NDA for Cladribine Tablets in the U.S.

Poll reveals that 43% of American adults undecided about getting the swine flu vaccine

Poll reveals that 43% of American adults undecided about getting the swine flu vaccine

Update from BioCryst Pharmaceuticals regarding intravenous peramivir

Update from BioCryst Pharmaceuticals regarding intravenous peramivir

CBR Pharma reports on M&A in the biopharmaceutical industry

CBR Pharma reports on M&A in the biopharmaceutical industry

Inspirion Delivery Technologies completes Pre-IND meeting with the FDA

Inspirion Delivery Technologies completes Pre-IND meeting with the FDA

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

Amicus Therapeutics to initiate Phase 1 study of AT2220

Amicus Therapeutics to initiate Phase 1 study of AT2220

Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations

Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations

FDA approves Mylan Pharmaceuticals' Carbidopa and Levodopa tablets

FDA approves Mylan Pharmaceuticals' Carbidopa and Levodopa tablets

Sun Pharma Global issues notice to Labopharm regarding its generic versions of Ryzolt

Sun Pharma Global issues notice to Labopharm regarding its generic versions of Ryzolt

Orphan drug designation for pixantrone applied by Cell Therapeutics

Orphan drug designation for pixantrone applied by Cell Therapeutics

IDRI and Academia Sinica sign Memorandum of Understanding

IDRI and Academia Sinica sign Memorandum of Understanding

Mellow Hope granted H1N1 license by SFDA

Mellow Hope granted H1N1 license by SFDA

FDA's Structured Product Labeling to be discussed

FDA's Structured Product Labeling to be discussed

Non-human primate study results of Restanza released

Non-human primate study results of Restanza released

Tβ4 therapy in EAE mice improves neurological functional recovery

Tβ4 therapy in EAE mice improves neurological functional recovery

Sanofi-aventis announces study results comparing efficacy of Lantus to detemir

Sanofi-aventis announces study results comparing efficacy of Lantus to detemir

SATAI invests $1.045 million in Azaya Therapeutics

SATAI invests $1.045 million in Azaya Therapeutics

New anticoagulant therapy has fewer side-effects than warfarin

New anticoagulant therapy has fewer side-effects than warfarin

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.